The invention relates to the fields of pharmaceutics and medicine and more specifically concerns the production and use of pharmaceutical compositions of drugs (ophthalmic preparations) containing a mitochondria-targeted antioxidant and a set of auxiliary substances, which provide for the efficient healing of ophthalmic diseases in human beings and animals.